AML Comboquest 9
- Sample Type
- Whole Blood
- Fasting
- No
- Unit
- Presence/Absence
Function
AML Comboquest 9 is a specialized molecular panel designed to identify key genetic mutations and chromosomal abnormalities associated with Acute Myeloid Leukemia (AML). This panel utilizes advanced techniques like Polymerase Chain Reaction (PCR) or Next-Generation Sequencing (NGS) to look for specific 'driver' mutations that influence how leukemia develops and responds to treatment.
Why it is Ordered
When a patient is newly diagnosed with AML, determining the genetic profile of the leukemia cells is the single most important factor for prognosis. This test is ordered to risk-stratify patients into 'favorable,' 'intermediate,' or 'adverse' categories. The results help oncologists decide whether a patient requires standard chemotherapy alone or if they are a candidate for targeted therapies or a stem cell transplant.
Associated Conditions
- Acute Myeloid Leukemia (AML): The primary condition being profiled.
- Myelodysplastic Syndromes (MDS): Sometimes ordered if there is a progression from MDS to AML.
- Targeted Therapy Selection: Identifying mutations like FLT3, NPM1, or CEBPA allows for the use of specific inhibitors.
Summary
The AML Comboquest 9 panel is a cornerstone of precision medicine in hematology. By understanding the molecular 'blueprint' of the cancer, clinicians can move beyond a one-size-fits-all approach to leukemia treatment, significantly improving the chances of achieving and maintaining remission.
Check Your Result
Check Your Result
Enter your lab result to see where you stand compared to the standard reference range.
Why Context Matters
Molecular testing for leukemia is highly complex. The timing of the sample (pre-treatment vs. post-treatment) and the site of collection (peripheral blood vs. bone marrow) can result in varying 'variant allele frequencies' (VAF). Additionally, different labs may use different detection thresholds, meaning a mutation found in one lab might be 'below the limit of detection' in another.
Lab ranges are statistical averages, not biological laws. "Normal" for a 20-year-old male isn't normal for a 60-year-old female.
Clinical References
Source-of-truth databases and clinical guidelines for AML Comboquest 9:
Official Sources
Research & Guidelines
- PubMed: AML Comboquest 9 Clinical GuidelinesNCBI / PubMed
Related Indicators
Medically Reviewed by Dr. Binoy Babu, MBBS
Board Certified Doctor • 10+ Years Clinical Experience
Dr. Babu is a practicing physician dedicated to empowering patients with clear, actionable medical information. He founded 2opi to bridge the gap between complex lab reports and patient understanding, ensuring everyone has access to a reliable second opinion.
Get Notified When Dr. Babu Is Available